Yurvac RHD
Active substance
ATC code
Species
Rabbits, including pet (dwarf) rabbits.
Indications
For active immunisation of rabbits from 30 days of age onwards to reduce mortality of rabbit haemorrhagic disease (RHD) caused by classical RHD virus (RHDV) and variant strains (RHDV2), including highly virulent strains.
For passive immunisation against RHDV2 in kits born to does vaccinated between 9 and 2 months before parturition, shown by challenge at 30 days of age.
|
Onset of immunity: |
7 days for RHDV2 14 days for RHDV. |
|
Duration of immunity: |
1 year |
Dose to be administered and administration route
Subcutaneous use.
Primary vaccination:
Administer one dose (0.5 ml) subcutaneously to rabbits from 30 days of age onwards.
Revaccination:
Revaccinate annually with one dose (0.5 ml) by subcutaneous injection.
Allow the vaccine to reach room temperature before use.
Shake well before administration.
Adverse reactions
Rabbits, including pet (dwarf) rabbits:
Very common (>1 animal / 10 animals treated): | Elevated temperature1 Injection site inflammation2 |
1 The highest individual rectal temperature increase was 1.52 ºC which returned to normal values 24 hours later.
2 Inflammation (< 2 cm) at the injection can be observed. These local reactions gradually reduce and disappear within 7 days without need for treatment.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
